MARKET WIREYahoo! Finance Canada • 1d ago
Spectral AI, Inc. (MDAIW) Stock Price, News, Quote & HistoryYahoo! Finance Canada report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.
Why MDAI Stock slipped -0.65% Today — RQD Quant Desk Flash
$1.52 -0.65% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $1.52
Spectral AI Inc. (Class A) (MDAI) carries a Roarable Rating of E (Strong Sell) with 16/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $49.2M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on MDAI Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is MDAI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Spectral AI Inc. (Class A) (NASDAQ: MDAI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 16/100 at a spot price of $1.52 (-0.65% 1D, market cap $49.2M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 4/20, FRED Macro Regime Fit 3/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, MDAI ranks #1011 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does MDAI compare to SRTS and DXR in the Health Care sector?
▼
Within the Health Care sector (Medical/Dental Instruments), MDAI carries a Roarable E (16/100 RQD), trailing P/E of N/A, gross margin of 45.4%, and ROIC of -35.0%. By comparison, SRTS (Sensus Healthcare Inc.) holds a D- grade (41/100 RQD, P/E N/A, ROIC -31.3%, cap $45.4M) and DXR (Daxor Corporation) posts a D grade (47/100 RQD, P/E N/A, ROIC —, cap $53.7M). Among the 5-stock peer group, SNWV leads on earnings multiple (3.8x) while SNWV leads on capital efficiency (67.3% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for MDAI?
▼
Per MDAI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001833498), Spectral AI Inc. (Class A) generated $19.6M in revenue (-33.6% YoY), -$7.6M in net income, and -$9.9M in free cash flow against $21.4M in total assets and $5.5M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $1.52 (-0.31%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 3/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (16/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-12.7% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
3-of-3 Quant Analysts Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR RQD RADARRw E · Rk E
Each axis scored 0–20
12M PRICE TARGET CONE-19.1% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MDAI)Realized 20D OHLCV Swing Band: ±8%
Deterministic 5-Pillar Attribution (16/100 Composite)
🔍 WHY MDAI SCORES 16/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+6/20 pts (38% of score)
20D Institutional Volume Accumulation (±8% realized swing band)
▲ #2 Bullish Driver: Cash Engine Quality+4/20 pts (25% of score)
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 45.4% Gross Margin
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$1.56-3.2% Next Q
24
Q2 (-2Q)Grade E$1.51+1.3% Next Q
21
Q3 (-1Q)Grade E$1.53-0.7% Next Q
19
CurrentGrade E$1.52-12.7% Hist 90D α
16
Trajectory: E (24) → E (16)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a MDAI Turnaround Squeeze
While MDAI currently carries a cautious 16/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.58) and Max Pain ($1.60) forces dealer call-delta covering toward $3.12.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $MDAI• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “MDAI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why MDAI Stock slipped -0.65% Today — RQD Quant Desk Flash
Spectral AI Inc. (Class A) (MDAI) slipped -0.65% to $1.52, trading at 19% of its 52-week range ($1.18 – $2.97). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 19% of its 52-week range ($1.18 – $2.97) with RSI-14 at 46.1 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±8% around $1.52 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 45.4% gross margin and $0 annual free cash flow.
Live MDAI Headlines & Catalysts
MARKET WIREYahoo Finance UK • 1d ago
Spectral AI, Inc. (MDAI) Seasonal returns chartYahoo Finance UK report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.
MARKET WIREhttps://www.dars.gov.et/ • 1d ago
Spectral AI (MDAI) Slips 2.55% to $1.53 as Shares Test Lower End of Recent Range - Negative Gammahttps://www.dars.gov.et/ report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingKey • 1d ago
Most Active Stocks Today: U.S. MarketTradingKey report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo! Finance Canada • 1d ago
QScreen AI Inc. (QAI.CN) Seasonal Returns Chart - Yahoo FinanceYahoo! Finance Canada report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.
CATALYSTTradingKey • 1d ago
Top U.S. Stock Gainers: Biggest Price IncreasesTradingKey report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingKey • 1d ago
Top U.S. Stock Losers: Biggest Price DeclinesTradingKey report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo • 6d ago
Spectral AI Schedules 2026 Third Quarter Financial Results and Conference CallDALLAS, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment d
MARKET WIREYahoo • 21d ago
Spectral AI’s DeepView™ System Showcased at the 2026 American College of Emergency Physicians (ACEP) Scientific AssemblyDALLAS, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment d
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MDAI)
- ✓Walkthrough of MDAI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
MDAI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -33.04%🛡️ HOLDING TREND SUPPORT
2026-11-03O $1.57H $1.57L $1.52C $1.52VOL 120.8K
RES: $1.81SUP: $1.41SMA50: $1.58SMA200: $1.70
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
MDAI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth
vs. -33.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on MDAI today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for MDAI. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for MDAI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MDAI)
Health Care Rank #1011 of 1015
⚔️ SRTS vs MDAI Full Matrix →
1. Head-to-Head Health Care Peer Comparison (MDAI vs. SRTS, DXR, SNWV, DAVI)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1015 tracked Health Care securities in the Roarable RQD universe, Spectral AI Inc. (Class A) (MDAI) ranks #1011 by composite RQD confidence (16/100, grade E) and #748 by equity capitalization ($49.2M). Within this direct 5-issuer industry benchmark cohort, SNWV leads on earnings valuation at 3.8x trailing P/E, while SNWV leads on capital efficiency and profitability with 67.3% ROIC and 77.1% gross margin. SNWV currently holds the highest overall quantitative score in the immediate peer group at 51/100 (D) compared with MDAI at 16/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| MDAI
ACTIVE
Spectral AI Inc. (Class A) | E | 16/100 | — | 45.4% | -35.0% | -0.65% | $49.2M | Benchmark Subject |
| SRTS Sensus Healthcare Inc. | D- | 41/100 | — | 43.2% | -31.3% | -0.36% | $45.4M | /srts-vs-mdai → |
| DXR Daxor Corporation | D | 47/100 | — | — | — | -2.17% | $53.7M | /dxr-vs-mdai → |
| SNWV SANUWAVE Health Inc. | D | 51/100 | 3.8x | 77.1% | 67.3% | +13.59% | $44.3M | /snwv-vs-mdai → |
| DAVI Davion Healthcare Plc | D | 47/100 | — | — | — | -11.31% | $42.0M | /davi-vs-mdai → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001833498 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), Spectral AI Inc. (Class A) (MDAI) reported GAAP revenue of $19.6M (-33.6% vs. FY2024 revenue of $29.6M , and +8.8% cumulative change since FY2023) , GAAP net income of -$7.6M, operating cash flow of -$9.9M, and free cash flow of -$9.9M (-7.8% YoY). On the balance sheet, MDAI closed FY2025 with $21.4M in total assets against $5.5M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 2/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $19.6M | -$7.6M | -$9.9M | -$9.9M | $21.4M | $5.5M |
| FY2024 (FY) | 2024-12-31 | $29.6M | -$15.2M | -$9.2M | -$9.2M | $12.1M | — |
| FY2023 (FY) | 2023-12-31 | $18.1M | -$20.9M | -$13.2M | -$13.2M | — | — |
3. MDAI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs MDAI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Spectral AI Inc. (Class A) (NASDAQ: MDAI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 16/100 at a spot price of $1.52 (-0.65% 1D, market cap $49.2M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 4/20, FRED Macro Regime Fit 3/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, MDAI ranks #1011 in composite RQD confidence.
How does MDAI compare to SRTS and DXR in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), MDAI carries a Roarable E (16/100 RQD), trailing P/E of N/A, gross margin of 45.4%, and ROIC of -35.0%. By comparison, SRTS (Sensus Healthcare Inc.) holds a D- grade (41/100 RQD, P/E N/A, ROIC -31.3%, cap $45.4M) and DXR (Daxor Corporation) posts a D grade (47/100 RQD, P/E N/A, ROIC —, cap $53.7M). Among the 5-stock peer group, SNWV leads on earnings multiple (3.8x) while SNWV leads on capital efficiency (67.3% ROIC).
What are the biggest fundamental strengths and SEC risk factors for MDAI?
Per MDAI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001833498), Spectral AI Inc. (Class A) generated $19.6M in revenue (-33.6% YoY), -$7.6M in net income, and -$9.9M in free cash flow against $21.4M in total assets and $5.5M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Where is MDAI trading relative to its 50-day, 200-day, and 52-week technical levels?
MDAI last traded at $1.52 (-0.65% on volume of 131,796 shares), positioning the stock -3.80% below its 50-day simple moving average ($1.58) and -10.59% below its 200-day simple moving average ($1.70). Across its 52-week range of $1.18 to $2.97, MDAI sits at the 19.0% percentile with a 14-day RSI of 46.1 (NEUTRAL RANGE) and an implied next-earnings move of ±8.0% ($1.40 to $1.64).
ROARABLE RATING BRIEF • RQD 16/100 (E)
✓ SEC XBRL & RQD VERIFIED
MDAI — Spectral AI Inc. (Class A): What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31
1. Roarable Rating Brief: What This Means to a Prospective Investor
Spectral AI Inc. (Class A) (MDAI) earns a live Roarable RQD composite score of 16/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $1.52 (-0.65% 1D, market capitalization $49.2M).
- Fundamental Cash Engine (3/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 45.4%, operating margin of -43.8%, and free cash flow yield of -19.63%.
- Whale 13F & Options Flow (6/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (3/20) + Forensic Balance Sheet (4/20): Incorporates a 1.00x equity beta, Altman Z-Score of 0.20, Piotroski F-Score of 2/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
Spectral AI Inc. (Class A) is listed on NASDAQ under the ticker MDAI and is classified in the Health Care sector and the Medical/Dental Instruments industry. The profile does not describe its products, customers, or revenue model. Revenue for FY 2025 is reported at $19. Gross margin is reported at 45.4% per market data.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Spectral AI Inc. (Class A) (MDAI) reported $19.6M in annual revenue (up from $29.6M in FY2024, -33.6% YoY) and -$7.6M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($18.1M revenue, -$20.9M net income) through FY2025, MDAI scaled operating cash flow to -$9.9M and free cash flow to -$9.9M, backed by $21.4M in total assets against $5.5M in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (E • RQD 16/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of -19.63% and institutional whale pillar of 6/20. With Fundamental Cash Engine at 3/20 and Institutional Whale Flow at 6/20, sustained execution supports upside toward the upper end of the $1.18 – $2.97 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -43.8% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Upstream suppliers, downstream customers, and sector correlations beyond the Health Care sector and Medical/Dental Instruments industry classification are — A prospective investor would need external supply-chain disclosure to assess second-order bottlenecks.
- Key Question #1: Can MDAI sustain or expand its -43.8% operating margin and -35.0% ROIC against Medical/Dental Instruments peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $19.6M and free cash flow of -$9.9M, how will capital allocation balance growth reinvestment against $5.5M in total debt?
- Key Question #3: How sensitive is MDAI's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
MDAI Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Spectral AI Inc. (Class A) (MDAI) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo! Finance Canada • 1d ago
Spectral AI, Inc. (MDAIW) Stock Price, News, Quote & History Yahoo! Finance Canada report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance UK • 1d ago
Spectral AI, Inc. (MDAI) Seasonal returns chart Yahoo Finance UK report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE https://www.dars.gov.et/ • 1d ago
Spectral AI (MDAI) Slips 2.55% to $1.53 as Shares Test Lower End of Recent Range - Negative Gamma https://www.dars.gov.et/ report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingKey • 1d ago
Most Active Stocks Today: U.S. Market TradingKey report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo! Finance Canada • 1d ago
QScreen AI Inc. (QAI.CN) Seasonal Returns Chart - Yahoo Finance Yahoo! Finance Canada report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST TradingKey • 1d ago
Top U.S. Stock Gainers: Biggest Price Increases TradingKey report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingKey • 1d ago
Top U.S. Stock Losers: Biggest Price Declines TradingKey report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo • 6d ago
Spectral AI Schedules 2026 Third Quarter Financial Results and Conference Call DALLAS, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment d
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
MDAI Bull vs. Bear Conversation Board — What's Your Call at $1.52?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON MDAI 🐻 33% BEARISH CONVICTION
SI SiliconVal_Bull RQD DEBATE OPENER • Growth & Tech Investor 🐂 BULLISH
🎯 Target: $1.88 (+22.9%)
📌 Pinned Debate Cash of $15.4M exceeds reported debt of $5.5M in FY 2025 while market data shows gross margin of 45.4%.
The street is overcomplicating Spectral AI Inc. (Class A) (MDAI). Cash of $15.4M exceeds reported debt of $5.5M in FY 2025 while market data shows gross margin of 45.4%.. With an RQD score of 16/100 (E) and Forensic Balance Sheet at 4/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $1.65.
RetailWhale_TX 🐂 BULL
Both sides have a point here — MDAI's 4/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.
RE RedlineAuditor RQD DEBATE OPENER • Accounting Quality Watch 🐻 BEARISH
🎯 Target: $1.32 (-13.7%)
Spot @ $1.53 Operating margin of -43.8%, ROIC of -35%, and Altman Z-Score of 0.2 signal severe cash burn and financial distress.
I respect the product at Spectral AI Inc. (Class A), but the stock at $1.53 is a different story. Operating margin of -43.8%, ROIC of -35%, and Altman Z-Score of 0.2 signal severe cash burn and financial distress.. FCF yield is -19.63% and RQD sits at 16/100 (E) — why pay up here when you can wait for next quarter's numbers?